ALTRIA GROUP, INC.
MOAPI behind this page
MO Q3 2025 request
Playground key active
/api/financials?ticker=MO&year=2025&quarter=3
Pick an endpoint and run the request.
Income Statement
| Metric | Q3 2025 | Q3 2024 | YoY |
|---|---|---|---|
| Revenue | 6,072 | 6,259 | -3.0% |
Show Business Segments breakouts |
|||
| All Other Segments | -4 | -3 | -33.3% |
| All Other Segments · Operating Segments | -76 | -119 | +36.1% |
| Oral Tobacco Products [Member] | 689 | 722 | -4.6% |
| Smokeable Products Segment [Member] | 5,387 | 5,540 | -2.8% |
| Cost of Revenue | 1,439 | 1,536 | -6.3% |
| Other Cost Of Operating Revenue | 821 | 915 | -10.3% |
| Gross Profit | 3,812 | 3,808 | +0.1% |
| Marketing Administrationand Research Costs | 580 | 656 | -11.6% |
| Asset Impairmentand Business Exit Costs | 2 | — | — |
Show Business Segments breakouts |
|||
| Smokeable Products Segment [Member] · Operating Segments | 2 | — | — |
Show Consolidation Items breakouts |
|||
| Operating Segments | 2 | — | — |
| Operating Income | 3,230 | 3,152 | +2.5% |
Show Business Segments breakouts |
|||
| Oral Tobacco Products [Member] · Operating Segments | 459 | 464 | -1.1% |
| Smokeable Products Segment [Member] | 2,942 | 2,937 | +0.2% |
| Smokeable Products Segment [Member] · Operating Segments | 2,942 | 2,937 | +0.2% |
| Interest Income Expense Nonoperating Net | 278 | 267 | +4.1% |
| Net Periodic Defined Benefits Expense Reversal Of Expense Excluding Service Cost Component | -16 | -25 | +36.0% |
Show Equity Components breakouts |
|||
| Accumulated Defined Benefit Plans Adjustment Net Prior Service Cost Credit · Reclassification Out Of Accumulated Other Comprehensive Income | -9 | -9 | 0.0% |
| Accumulated Defined Benefit Plans Adjustment Net Unamortized Gain Loss · Reclassification Out Of Accumulated Other Comprehensive Income | 10 | 7 | +42.9% |
| Accumulated Defined Benefit Plans Adjustment · Reclassification Out Of Accumulated Other Comprehensive Income | 1 | -2 | +150.0% |
| Gain Loss From Equity Securities | -107 | -116 | +7.8% |
| Income Before Taxes | 3,075 | 3,026 | +1.6% |
| Income Tax Expense (Benefit) | 700 | 733 | -4.5% |
| Net Income | 2,375 | 2,293 | +3.6% |
| EPS (Basic) | 1.41 | 1.34 | +5.2% |
| EPS (Diluted) | 1.41 | 1.34 | +5.2% |
| General & Administrative (Q) | — | — | — |
Show Consolidation Items breakouts |
|||
| Corporate Non Segment | -57 | -92 | +38.0% |
| Comprehensive Income | 2,497 | 1,959 | +27.5% |
| Wtd Avg Shares (Basic) | 1,680 | 1,703 | -1.4% |
| Wtd Avg Shares (Diluted) | 1,680 | 1,703 | -1.4% |
| Net Income Loss Available To Common Stockholders Basic | 2,369 | 2,287 | +3.6% |
| Income Loss From Equity Method Investments | -107 | -116 | +7.8% |
Show Equity Components breakouts |
|||
| ABI [Member] · Reclassification Out Of Accumulated Other Comprehensive Income | -3 | 1 | -400.0% |
Show Schedule Of Equity Method Investment Equity Method Investee Name breakouts |
|||
| ABI [Member] | -123 | -121 | -1.7% |
| Cronos Group Inc. [Member] | 16 | 5 | +220.0% |
Balance Sheet
| Metric | Q3 2025 | Q3 2024 | YoY |
|---|---|---|---|
| Current Assets | |||
| Cash & Cash Equivalents | 3,472 | 1,897 | +83.0% |
| Other Receivables Net Current | 249 | 87 | +186.2% |
| Inventory | 1,065 | 1,101 | -3.3% |
| Other Assets Current | 333 | 210 | +58.6% |
| Total Current Assets | 5,119 | 3,499 | +46.3% |
| Non-Current Assets | |||
| Property, Plant & Equipment | 1,617 | 1,618 | -0.1% |
| Goodwill | 6,072 | — | — |
Show Business Segments breakouts |
|||
| All Other Segments | 895 | — | — |
| Oral Tobacco Products [Member] | 5,078 | — | — |
| Smokeable Products Segment [Member] | 99 | — | — |
| Other Non-Current Assets | 949 | 942 | +0.7% |
| Total Assets | 35,008 | 34,167 | +2.5% |
| Other Assets | |||
| Inventory Raw Materials Plant Material Netof Reserves | 502 | 524 | -4.2% |
| Other Inventory Raw Materials Netof Reserves | 208 | 189 | +10.1% |
| Inventory Work In Process Net Of Reserves | 19 | 26 | -26.9% |
| Inventory Finished Goods Net Of Reserves | 336 | 362 | -7.2% |
| Property Plant And Equipment Gross | 4,547 | 4,518 | +0.6% |
| Accumulated Depreciation Depletion And Amortization Property Plant And Equipment | 2,930 | 2,900 | +1.0% |
| Intangible Assets Net Excluding Goodwill | 12,866 | 13,010 | -1.1% |
Show Business Segments breakouts |
|||
| All Other Segments | 1,294 | 1,379 | -6.2% |
| Oral Tobacco Products [Member] | 8,654 | 8,687 | -0.4% |
| Smokeable Products Segment [Member] | 2,918 | 2,944 | -0.9% |
| Investments | 8,385 | 8,153 | +2.8% |
| Current Liabilities | |||
| Current Portion of Long-Term Debt | 1,569 | 1,585 | -1.0% |
| Accounts Payable | 662 | 510 | +29.8% |
| Accrued Marketing Costs Current | 886 | 817 | +8.4% |
| Accrued Settlement Liability Current | 1,887 | 2,118 | -10.9% |
| Other Accrued Liabilities Current | 1,495 | 1,227 | +21.8% |
| Dividends Payable Current | 1,787 | 1,739 | +2.8% |
| Total Current Liabilities | 8,286 | 7,996 | +3.6% |
| Non-Current Liabilities | |||
| Long-Term Debt | 24,132 | 23,570 | +2.4% |
| Deferred Tax Liabilities | 3,462 | 3,208 | +7.9% |
| Defined Benefit Pension Plan Liabilities Noncurrent | 133 | 125 | +6.4% |
| Other Postretirement Defined Benefit Plan Liabilities Noncurrent | 931 | 1,090 | -14.6% |
| Other Non-Current Liabilities | 660 | 1,596 | -58.6% |
| Total Liabilities | 37,604 | 37,585 | +0.1% |
| Long-Term Debt | 25,701 | 25,155 | +2.2% |
Show Debt Instrument breakouts |
|||
| Foreign Currency Denominated Debt [Member] | 2,635 | 3,334 | -21.0% |
| Stockholders' Equity | |||
| Common Stock | 935 | 935 | 0.0% |
| Additional Paid In Capital Common Stock | 5,906 | 5,890 | +0.3% |
| Retained Earnings | 36,115 | 34,206 | +5.6% |
| Accumulated Other Comprehensive Income | -2,709 | -2,617 | -3.5% |
| Treasury Stock Value | -42,893 | -41,882 | -2.4% |
| Total Stockholders' Equity | -2,646 | -3,468 | +23.7% |
| Minority Interest | 50 | 50 | 0.0% |
| Stockholders Equity Including Portion Attributable To Noncontrolling Interest | -2,596 | -3,418 | +24.0% |
Show Equity Components breakouts |
|||
| ABI [Member] | -1,335 | -1,131 | -18.0% |
| Accumulated Defined Benefit Plans Adjustment | -1,388 | -1,497 | +7.3% |
| Accumulated Other Comprehensive Income | -2,709 | -2,617 | -3.5% |
| Accumulated Translation Adjustment | 14 | 11 | +27.3% |
| Additional Paid In Capital | 5,906 | 5,890 | +0.3% |
| Common Stock | 935 | 935 | 0.0% |
| Noncontrolling Interest | 50 | 50 | 0.0% |
| Retained Earnings | 36,115 | 34,206 | +5.6% |
| Treasury Stock Common | -42,893 | -41,882 | -2.4% |
| Total Liabilities & Equity | 35,008 | 34,167 | +2.5% |
Cash Flow Statement
| Metric | YTD Q3 2025 | YTD Q3 2024 | YoY |
|---|---|---|---|
| Operating Activities | |||
| Net Income | 5,830 | 8,225 | -29.1% |
Show Reclassification Out Of Accumulated Other Comprehensive Income breakouts |
|||
| Reclassification Out Of Accumulated Other Comprehensive Income | 26 | -253 | +110.3% |
| Depreciation & Amortization | 212 | 213 | -0.5% |
| Deferred Income Taxes | -194 | 459 | -142.3% |
| Income Tax Adjustments Unrecognized Tax Benefits | 291 | 80 | +263.8% |
| Fair Value Adjustment For Contingent Consideration Payments | 25 | — | — |
| Equity Method Investment Dividends Or Distributions | 181 | 139 | +30.2% |
| Asset Impairment And Business Exit Costs Net Of Cash Paid | -9 | 354 | -102.5% |
| Goodwill Impairment Charges Net Of Cash Paid | 873 | — | — |
| Increase Decrease In Receivables | -72 | -14 | -414.3% |
| Change in Inventory | -22 | 114 | -119.3% |
| Change in Accounts Payable | -30 | -68 | +55.9% |
| Increase Decrease In Accrued Income Taxes Payable | 404 | 396 | +2.0% |
| Increase Decrease In Other Current Assets And Liabilities Net | -856 | -919 | +6.9% |
| Increase Decrease In Settlement Payable | -467 | -445 | -4.9% |
| Pension Contributions | -11 | -13 | +15.4% |
| Pension And Other Postretirement Benefits Expense Reversal Of Expense Noncash | -60 | -76 | +21.1% |
| Other Operating Activities Cash Flow Statement | 322 | 198 | +62.6% |
| Net Cash from Operations | 6,019 | 5,413 | +11.2% |
| Investing Activities | |||
| Capital Expenditures | -124 | -95 | -30.5% |
| Other Investing Activities | -15 | -20 | +25.0% |
| Net Cash from Investing | -139 | 2,238 | -106.2% |
| Financing Activities | |||
| Proceeds From Issuance Of Long Term Debt | 1,992 | — | — |
| Repayments Of Long Term Debt | -1,607 | -1,121 | -43.4% |
| Share Repurchases | -712 | -3,090 | +77.0% |
| Payments Of Dividends Common Stock | -5,175 | -5,108 | -1.3% |
| Proceeds From Payments For Other Financing Activities | -40 | -125 | +68.0% |
| Net Cash from Financing | -5,542 | -9,444 | +41.3% |
| Other Cash Flow | |||
| Net Change in Cash | 338 | -1,793 | +118.9% |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 3,496 | 1,928 | +81.3% |
| Restricted Cash Current | 9 | 8 | +12.5% |
| Restricted Cash Noncurrent | 15 | 23 | -34.8% |
Values in millions USD. Source: SEC EDGAR 10-Q filing.